Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions and spanning the data center core to network edge in the United States, Argentina, China, India, Israel, Japa…
FAIL · Does not pass the screen
196.40 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 08:40 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Positioning political selling, disclosed 2026-09-24
Options put/call open interest 1.33, read 2026-11-01
Ethical does not pass the values gate
Price196.40 USD
Fair value205.96
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-11-01Read Distribution196.40+0.0% to today Markdown gives way to Distribution after a 19% slide in 7 days
2026-10-25Read Markdown241.24-18.6% to today ✓Accumulation gives way to Markdown after an 8% slide in 3 weeks
2026-10-02Read Accumulation261.94-25.0% to today Markup gives way to Accumulation with volume flow in agreement
2026-07-02Read Markup263.47-25.5% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Marvell Technology holds its Distribution at $196.40. Elevated stress, defensive posture warranted, held for 1 days.
As held on the ledger · 2026-10-30
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 1 days
Price at the screen
$196.40
Valuation
71.82 trailing · 29.79 forward price to earnings
Values screen
FAIL· score 10.0
Beta
2.26
The Workings
Five Screens, Shown in Full
Does not pass. Revenue purity 21.0%
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
21.50%
Below 33%
Interest-bearing debt is just 21.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
11.84%
Below 33%
Cash held in interest-bearing accounts and securities is 11.8% of assets, under the one-third limit.
Pass
Receivables
9.81%
Below 49%
Money owed to the company is 9.8% of assets, under the 49% limit.
Pass
Revenue purity
21.03%
Below 5%
21.0% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Marvell Technology clears the business-activity screen, and its debt is inside the line. Where it falls short is income purity: around 21% of its income right now is interest earned on a large cash position, against a roughly 5% ceiling, so it does not pass. That reflects what it earns today, not the business itself, and it could clear the screen if its operating revenue grows and the interest share falls.
Read as at 2026-11-01. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MRVL's ethical verdict changes
Today MRVL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited by BDS movement as an Israeli-founded semiconductor company with significant R&D operations in Israel. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads AVOID: it trades at roughly a 5% discount to our $205.96 fair value, 36.50% revenue growth.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 4.9% margin of safety to the base estimate.
Where our models see it going: fair-value estimate $205.96, with a range of $205.96 to $236.86, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Marvell's High-Priced Chips in a Cyclical Storm
Consider the world's data centers, the beating hearts of the internet, and Marvell Technology provides the semiconductors that power them. Yet, the chip industry is famously cyclical, and Marvell's current price of $251.01 is riding high on peak earnings. It's a warning sign, not a value play. Why it stands out. Despite these headwinds, Marvell boasts a forward P/E of 40.2x and a robust revenue growth of 28%. However, with a profit margin of 29% and a ROE of 16%, these numbers are亮眼 but not exceptional, especially when the market is currently pricing Marvell at a significant premium to our fair value estimate of $150.15, which represents a 40% discount to its current price.
Risk sits around the ethical performance of Marvell, which has failed our ethical screen, largely due to a revenue purity score of only 21.0%. The consensus rating is strong buy from 40 analysts, with a median target of $248, yet this is a market opinion, not a guarantee. In the cyclical semiconductor industry, the glimmer of high earnings can be a mirage, masking the underlying volatility that investors should be wary of. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MRVL trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 18.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 51% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. Since the last review it entered the Titan Ethical 500.
2026-10-25Markdown · changed$241.24+0.0%Entry 16
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 55% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150.
2026-10-18Accumulation$241.24-7.9%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 7.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150.
2026-10-11Accumulation$261.94+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150.
2026-08-27Markup$251.01+0.0%Entry 12
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-26Markup$251.01+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-25Markup$251.01+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$251.01+0.0%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Markup$251.01+0.0%Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
